Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co Ltd    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO LTD (600276)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
83.29(c) 80.87(c) 82.04(c) 83.03(c) 84.03 Last
162 870 166 656 138 487 97 606 136 024 Volume
+2.73% -2.91% +1.45% +1.21% +1.20% Change
More quotes
Financials (CNY)
Sales 2018 16 916 M
EBIT 2018 4 467 M
Net income 2018 3 912 M
Finance 2018 8 756 M
Yield 2018 0,15%
Sales 2019 21 295 M
EBIT 2019 5 686 M
Net income 2019 4 940 M
Finance 2019 11 849 M
Yield 2019 0,18%
P/E ratio 2018 60,34
P/E ratio 2019 47,53
EV / Sales2018 13,6x
EV / Sales2019 10,6x
Capitalization 238 B
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. engages in the research, development, manufacture, and sale of drugs.It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs.Its products include tablets, oral solution, and suspension of... 
Sector
Pharmaceuticals
Calendar
04/27Earnings Release
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
04/11JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
03/28JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
03/27JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
01/19JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
AQ
01/09TG THERAPEUTICS : and Jiangsu Hengrui Medicine Announce Global License Agreement..
AQ
01/08TG THERAPEUTICS, INC. (NASDAQ : TGTX) Files An 8-K Entry into a Material Definit..
AQ
01/05JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
BU
2017JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for for final dividend
FA
2017JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
FA
2016JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for for final dividend
FA
More news
Sector news : Pharmaceuticals - NEC
04/21TAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
01/08$TGTX: TG Therapeutics and Jiangsu Hengrui Medicine announce global license a.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
2017Oncolys Biopharma : Announces First Milestone from License Agreement with Jia.. 
More tweets
Qtime:52
Chart JIANGSU HENGRUI MEDICINE C
Duration : Period :
Jiangsu Hengrui Medicine C Technical Analysis Chart | 600276 | CNE0000014W7 | 4-Traders
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Average target price 86,6  CNY
Spread / Average Target 3,0%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou President & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO LTD21.82%37 816
JOHNSON & JOHNSON-8.71%339 783
PFIZER0.86%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571